AGENUS INC License Agreements

22 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
License, Development and Commercialization Agreement between Agenus Inc. and Bristol-Myers Squibb Company (May 17, 2021)
License Agreements
AGENUS INC
Biotechnology
NY
2021
License and Collaboration Agreement between Agenus Inc. and Betta Pharmaceuticals Co., Ltd.
License Agreements
AGENUS INC
Biotechnology
NY
2020
Option and License Agreement (AGEN2373) between Agenus Inc. and Gilead Sciences, Inc. dated December 20, 2018
License Agreements
AGENUS INC
Biotechnology
DE
2019
Option and License Agreement (AGEN1223) between Agenus Inc. and Gilead Sciences, Inc. dated December 20, 2018
License Agreements
AGENUS INC
Biotechnology
DE
2019
License Agreement between Agenus Inc. and Gilead Sciences, Inc. (December 20, 2018)
License Agreements
AGENUS INC
Biotechnology
DE
2019
First Amendment to License, Development and Commercialization Agreement between Agenus and Incyte
License Agreements
AGENUS INC
Biotechnology
MA
2017
License Agreement between Agenus Inc., 4-Antibody AG, and Ludwig Institute for Cancer Research Ltd. (January 25, 2016)
License Agreements
AGENUS INC
Biotechnology
NY
2016
License Agreement between University of Virginia Licensing & Ventures Group and PhosImmune, Inc.
License Agreements
AGENUS INC
Biotechnology
2016
License, Development and Commercialization Agreement between Agenus Inc., 4-Antibody AG, Incyte Europe Sarl, and Incyte Corporation
License Agreements
AGENUS INC
Biotechnology
NY
2015
License Agreement between 4-Antibody AG and Ludwig Institute for Cancer Research Ltd. (December 5, 2014)
License Agreements
AGENUS INC
Biotechnology
NY
2015
Exclusive License, Development, and Manufacturing Technology Transfer Agreement between Agenus Inc. and NewVac Ltd.
License Agreements
AGENUS INC
Biotechnology
MA
2012
Amended and Restated License Agreement between Antigenics, Inc. and Elan Pharma International Limited and Elan Pharmaceuticals, Inc.
License Agreements
AGENUS INC
Biotechnology
DE
2009
Letter Agreement Extending License Fee Obligation Deadline Between Antigenics Inc. and University of Connecticut Health Center
License Agreements
AGENUS INC
Biotechnology
2009
Amendment Number Two to License Agreement between University of Connecticut Health Center and Antigenics Inc.
License Agreements
AGENUS INC
Biotechnology
2009
Amendment No. 8 to Patent and Technology License Agreement between University of Texas and Aronex Pharmaceuticals, Inc.
License Agreements
AGENUS INC
Biotechnology
2008
Exclusive License Agreement between The University of Texas System and Argus Pharmaceuticals, Inc. (July 1, 1988)
License Agreements
AGENUS INC
Biotechnology
2008
Exclusive License Agreement between The Board of Regents of The University of Texas System, The University of Texas System Cancer Center, and The Macrophage Company, Inc. dated...
License Agreements
AGENUS INC
Biotechnology
2008
Amended and Restated License Agreement between Antigenics, Inc. and Sumitomo Pharmaceuticals Co., Ltd.
License Agreements
AGENUS INC
Biotechnology
2008
Amendments No. 1, 2, 3, 5, 6, and 7 to Exclusive License Agreement between The University of Texas System and Argus Pharmaceuticals, Inc.
License Agreements
AGENUS INC
Biotechnology
TX
2008
License Agreement among Aquila Biopharmaceuticals, Inc., Neuralab Limited, and Elan Biopharmaceuticals, Inc.
License Agreements
AGENUS INC
Biotechnology
DE
2007
License Agreement between Antigenics, Inc. and GlaxoSmithKline Biologicals SA
License Agreements
AGENUS INC
Biotechnology
DE
2006
Exclusive License Agreement between University of Connecticut Health Center and Antigenics, Inc. dated May 25, 2001
License Agreements
AGENUS INC
Biotechnology
NY
2003